SPORANOX CAPSULES
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ITRACONAZOLE 100 MG
Available from:
J-C HEALTH CARE LTD
ATC code:
J02AC02
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
JANSSEN CILAG S.P.A., ITALY
Therapeutic group:
ITRACONAZOLE
Therapeutic indications:
Blastomycosis (pulmonary and extrapulmonary). Histoplasmosis . Onychomycosis caused by dermatophytes and/or yeasts. Dermatomycoses. Vulvovaginal candidosis. Oral candidosis. Prevention of fungal infection during neutropenia in immunodeficient patients.
Authorization date:
2012-07-01
